Open AccessPredictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine–Induced Hand-Foot Syndrome
Author(s) -
Yoon Sim Yap,
LiLian Kwok,
Nicholas Syn,
Wen Yee Chay,
John Whay Kuang Chia,
Chee Kian Tham,
Nan Soon Wong,
Soo Kien Lo,
Rebecca Dent,
S. B. Tan,
Zuan Yu Mok,
King Xin Koh,
Han Chong Toh,
Wen Hsin Koo,
Marie Loh,
Raymond Ng,
Su Pin Choo,
Richie Chuan Teck Soong
Publication year - 2017
Publication title -
jama oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 8.846
H-Index - 99
eISSN - 2374-2445
pISSN - 2374-2437
DOI - 10.1001/jamaoncol.2017.1269
Subject(s) - medicine , capecitabine , placebo , adverse effect , clinical endpoint , pyridoxine , randomized controlled trial , gastroenterology , colorectal cancer , surgery , cancer , pathology , alternative medicine
Hand-foot syndrome (HFS) is a common adverse effect of capecitabine treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom